The Latest from Giddy
Minimally invasive and multifaceted, this approach can be more efficient than others.
When it comes to prostate cancer, is less actually more?
New analysis yields powerful insights by fusing trial data on radiation and hormonal therapy.
A new U.K. study creates an algorithm that may help to more precisely target at-risk men.
Most men experience some erectile difficulty during the first year; others face a longer road.
Brachytherapy uses radioactive pellets implanted in the tumor to treat prostate cancer.
Researchers hope the 'competition' yields results for technology that could hone diagnosis.
Patient participation, data sharing and advocacy drive research and treatment advances.
Trial results for Lu-PSMA-617 offer hope for men with metastatic, castration-resistant cancer.
Doctors try to avoid it, but in certain cases, tumor removal is the answer.
